Reforming Patent Law: The Case of Covid-19
Cato Journal
; 41(3):773-784, 2021.
Article
in English
| Scopus | ID: covidwho-1728063
ABSTRACT
A short time ago the debate over the proposal to temporarily waive intellectual property rights on Covid-19 vaccines was raging worldwide;and the suspension of those rights seemed imminent. Public attention reached its peak in May 2021 when the Biden administration endorsed the idea and committed itself to pursuing it under the World Trade Organization–World Intellectual Property Organization (WTO-WIPO) procedural rules for waiving intellectual property (IP) protection. By suspending IP rights, the administration sought to help low-income countries to start producing vaccines more quickly, reducing the rising and dramatic worldwide vaccine inequality. © Cato Institute. All rights reserved.
Search on Google
Collection:
Databases of international organizations
Database:
Scopus
Language:
English
Journal:
Cato Journal
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS